Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP15 | Q460N3 | 1/20 | 0.47 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
| ▸ | SOD1 | P00441 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | SNRNP200 | O75643 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | ACACB | O00763 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12015518 | 0.82 | PARP15 (0.49) | PARP15PARP10SNRNP200ALDH1A1SMN1; SMN2 | |
| SCHEMBL15607657 | 0.81 | PARP15 (0.43) | PARP15PARP10ALOX5SNRNP200TDP1 | |
| SCHEMBL15607658 | 0.81 | PARP15 (0.54) | PARP15PARP10ALOX5SNRNP200TDP1 | |
| SCHEMBL13347808 | 0.80 | L3MBTL1 (0.69) | SOD1TDP1L3MBTL1ALDH1A1KDM4E | |
| SCHEMBL278312 | 0.79 | ALOX5 (0.48) | PARP15PARP10SOD1ALOX5SNRNP200 | |
| SCHEMBL17307635 | 0.77 | PARP15 (0.50) | PARP15PARP10ALOX5SNRNP200TDP1 | |
| SCHEMBL15474277 | 0.77 | PARP15 (0.47) | PARP15PARP10ALOX5SNRNP200TDP1 | |
| SCHEMBL18347810 | 0.77 | PARP15 (0.44) | PARP15PARP10ALOX5SNRNP200TDP1 | |
| SCHEMBL28406646 | 0.76 | PARP15 (0.46) | PARP15PARP10ALOX5SNRNP200TDP1 | |
| SCHEMBL13505522 | 0.75 | NOS3 (0.44) | PARP15PARP10TDP1L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8133898-B2 | Renin inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-13 | — | — | US | disclosed |
| US-20100137310-A1 | RENIN INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137310-A1 | RENIN INHIBITORS | REN, ACE, PRSS3 | PARP15 801/4885PARP10 1691/4885SOD1 1616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.